Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 38% ± 19% | |
lung | 9 studies | 29% ± 11% | |
peripheral blood | 7 studies | 28% ± 10% | |
eye | 6 studies | 40% ± 18% | |
heart | 4 studies | 33% ± 8% | |
adipose | 4 studies | 36% ± 15% | |
bone marrow | 3 studies | 24% ± 6% | |
liver | 3 studies | 36% ± 17% | |
intestine | 3 studies | 18% ± 1% | |
kidney | 3 studies | 27% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 10937.19 | 21 / 21 | 100% | 41.96 | 504 / 504 |
breast | 100% | 10121.40 | 459 / 459 | 100% | 63.27 | 1118 / 1118 |
esophagus | 100% | 11136.32 | 1445 / 1445 | 100% | 61.01 | 183 / 183 |
prostate | 100% | 10967.89 | 245 / 245 | 100% | 34.93 | 502 / 502 |
stomach | 100% | 7547.95 | 359 / 359 | 100% | 41.07 | 286 / 286 |
uterus | 100% | 13199.39 | 170 / 170 | 100% | 50.08 | 459 / 459 |
thymus | 100% | 9542.03 | 653 / 653 | 100% | 42.98 | 604 / 605 |
intestine | 100% | 10299.87 | 966 / 966 | 100% | 35.65 | 526 / 527 |
ovary | 100% | 10513.18 | 180 / 180 | 100% | 53.38 | 429 / 430 |
lung | 100% | 11828.22 | 578 / 578 | 100% | 49.28 | 1152 / 1155 |
skin | 100% | 12139.66 | 1809 / 1809 | 100% | 35.84 | 470 / 472 |
kidney | 100% | 6906.16 | 89 / 89 | 99% | 32.12 | 892 / 901 |
liver | 100% | 5963.26 | 226 / 226 | 99% | 23.91 | 400 / 406 |
brain | 97% | 5807.80 | 2561 / 2642 | 99% | 25.77 | 698 / 705 |
pancreas | 97% | 3451.55 | 318 / 328 | 99% | 40.00 | 176 / 178 |
adrenal gland | 100% | 6654.57 | 258 / 258 | 94% | 21.41 | 217 / 230 |
adipose | 100% | 9470.19 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 47.26 | 29 / 29 |
muscle | 100% | 8351.05 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 15318.33 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 52.66 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 35.81 | 1 / 1 |
blood vessel | 100% | 6995.53 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 9901.67 | 919 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 23.36 | 79 / 80 |
heart | 99% | 5422.76 | 849 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0006482 | Biological process | protein demethylation |
GO_0006303 | Biological process | double-strand break repair via nonhomologous end joining |
GO_0010944 | Biological process | negative regulation of transcription by competitive promoter binding |
GO_0006338 | Biological process | chromatin remodeling |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005694 | Cellular component | chromosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0032452 | Molecular function | histone demethylase activity |
GO_0045322 | Molecular function | unmethylated CpG binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0140680 | Molecular function | histone H3K36me/H3K36me2 demethylase activity |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0051864 | Molecular function | histone H3K36 demethylase activity |
Gene name | KDM2A |
Protein name | F-box and leucine-rich repeat protein 11, isoform CRA_a (Lysine-specific demethylase 2A) Lysine-specific demethylase 2A (EC 1.14.11.27) (CXXC-type zinc finger protein 8) (F-box and leucine-rich repeat protein 11) (F-box protein FBL7) (F-box protein Lilina) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A) Alternative protein KDM2A Lysine demethylase 2A (N-terminus deleted lysine-specific demethylase 2A) |
Synonyms | KIAA1004 FBL7 JHDM1A CXXC8 FBL11 hCG_21062 FBXL11 |
Description | FUNCTION: Histone demethylase that specifically demethylates 'Lys-36' of histone H3, thereby playing a central role in histone code. Preferentially demethylates dimethylated H3 'Lys-36' residue while it has weak or no activity for mono- and tri-methylated H3 'Lys-36'. May also recognize and bind to some phosphorylated proteins and promote their ubiquitination and degradation. Required to maintain the heterochromatic state. Associates with centromeres and represses transcription of small non-coding RNAs that are encoded by the clusters of satellite repeats at the centromere. Required to sustain centromeric integrity and genomic stability, particularly during mitosis. Regulates circadian gene expression by repressing the transcriptional activator activity of CLOCK-BMAL1 heterodimer and RORA in a catalytically-independent manner . . |
Accessions | ENST00000530342.2 [Q9Y2K7-5] I3VM53 ENST00000308783.9 L0R5B6 ENST00000398645.6 [Q9Y2K7-3] Q9Y2K7 ENST00000529006.7 [Q9Y2K7-1] I3VM54 |